Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2018 Filed Jan 9, 2018 21:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Exercise / conversionCommon Stock | 2,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002952 · doc4.xml · nonDerivative · entry 3 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Tax withholdingCommon Stock | 5,818 | $49.20 | $286,245.60 |
DisclosureSEC source: 0001209191-18-002952 · doc4.xml · nonDerivative · entry 2 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,833 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
GrantCommon Stock | 11,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002952 · doc4.xml · nonDerivative · entry 1 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,651 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2014 for the 3-year period beginning on January 1, 2015 and ended December 31, 2017 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 5, 2018. The Company's Relative TSR measured in the 95th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 05, 2018 Filed Jan 19, 2018 22:13 UTC Amendment |
Jackson Denise LChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 3,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-004595 · doc4a.xml · derivative · entry 7 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,048 Underlying: Common Stock · 3,048 shares Expires not disclosed F10 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F11 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F9 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 19, 2018 22:13 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-004595 · doc4a.xml · derivative · entry 6 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,256 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F8 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2015 and vest on the third anniversary of the grant date and the grantee's provision of three periods of credited service. F9 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 19, 2018 22:13 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 847 | $49.20 | $41,672.40 |
DisclosureSEC source: 0001209191-18-004595 · doc4a.xml · nonDerivative · entry 4 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,112 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 19, 2018 22:13 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Exercise / conversionCommon Stock | 2,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-004595 · doc4a.xml · nonDerivative · entry 3 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| January 05, 2018 Filed Jan 19, 2018 22:13 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 3,314 | $49.20 | $163,048.80 |
DisclosureSEC source: 0001209191-18-004595 · doc4a.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,703 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 19, 2018 22:13 UTC Amendment |
Jackson Denise LChief Legal Officer
|
GrantCommon Stock | 8,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-004595 · doc4a.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,017 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2014 for the 3-year period beginning on January 1, 2015 and ended December 31, 2017 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 5, 2018. The Company's Relative TSR measured in the 95th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 02:37 UTC |
SALKA SUSAN RDirector · President and CEO
|
Exercise / conversionPerformance Restricted Stock Units · Derivative | 58,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001593 · doc4.xml · derivative · entry 3 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,935 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The PRSUs set forth in this row resulted from the vesting of a PRSU award granted by the Company on January 3, 2014. On February 16, 2017, the maximum number of PRSUs that could have been earned, 58,935, were deemed earned and vested under the January 3, 2014 PRSU award. F5 · derivative.expiration_date: PRSUs do not have an expiration date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 02:37 UTC |
SALKA SUSAN RDirector · President and CEO
|
Tax withholdingCommon Stock | 20,373 | $49.25 | $1,003,370.25 |
DisclosureSEC source: 0001209191-18-001593 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,412 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 02:37 UTC |
SALKA SUSAN RDirector · President and CEO
|
GrantCommon Stock | 58,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001593 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,785 F1 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the deferred release of a Performance Restricted Stock Unit ("PRSU") award that vested on February 16, 2017. In 2014, the reporting person elected to defer receipt of these PRSUs pursuant to the Company's deferred compensation plan, with a settlement date of January 2, 2018. Read SEC document |
| December 19, 2017 Filed Dec 20, 2017 22:01 UTC |
SALKA SUSAN RDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 20,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066670 · doc4.xml · derivative · entry 3 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,429 Underlying: Common Stock · 20,429 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units were granted on December 19, 2017 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33% should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2018 fiscal year, and on the second anniversary of the grant date in the amount of 34% should the Company achieve or exceed the specified EBITDA target for the 2019 fiscal year. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| December 09, 2017 Filed Dec 13, 2017 00:19 UTC |
SALKA SUSAN RDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 12,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065287 · doc4.xml · derivative · entry 3 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: The RSUs identified in this row were granted on December 9, 2014 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2015 fiscal year, and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2016 fiscal year. F5 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| December 09, 2017 Filed Dec 13, 2017 00:19 UTC |
SALKA SUSAN RDirector · President and CEO
|
Tax withholdingCommon Stock | 5,357 | $50.15 | $268,653.55 |
DisclosureSEC source: 0001209191-17-065287 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,974 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| December 09, 2017 Filed Dec 13, 2017 00:19 UTC |
SALKA SUSAN RDirector · President and CEO
|
Exercise / conversionCommon Stock | 12,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065287 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 20:48 UTC |
WHEAT DOUGLAS DDirector
|
SaleCommon Stock | 3,793 | $50.23 | $190,522.39 |
DisclosureSEC source: 0001209191-17-064375 · doc4.xml · nonDerivative · entry 1 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in this row represents a weighted average price of $50.23 per share. These shares were sold in multiple transactions at prices ranging from $50.05 to $50.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 29, 2017 Filed Dec 2, 2017 00:24 UTC |
Weaver Paul EDirector
|
SaleCommon Stock | 1,257 | $50.25 | $63,164.25 |
DisclosureSEC source: 0001209191-17-063327 · doc4.xml · nonDerivative · entry 2 Weaver Paul E · CIK 0001363498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,969 Read SEC document |
| November 29, 2017 Filed Dec 2, 2017 00:24 UTC |
Weaver Paul EDirector
|
SaleCommon Stock | 8,743 | $50.28 | $439,554.33 |
DisclosureSEC source: 0001209191-17-063327 · doc4.xml · nonDerivative · entry 1 Weaver Paul E · CIK 0001363498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,226 F1 · price: The price reported in this row represents a weighted average price of $50.275 per share. These shares were sold in multiple transactions at prices ranging from $50.25 to $50.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 29, 2017 Filed Dec 2, 2017 00:21 UTC |
Scott Brian M.CFO/CAO
|
SaleCommon Stock | 10,000 | $50.26 | $502,625.00 |
DisclosureSEC source: 0001209191-17-063325 · doc4.xml · nonDerivative · entry 2 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,916 F1 · kind: The sale of 10,000 shares of AMN Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in this row represents a weighted average price of $50.2625 per share. These shares were sold in multiple transactions at prices ranging from $50.15 to $50.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 29, 2017 Filed Dec 2, 2017 00:21 UTC |
Scott Brian M.CFO/CAO
|
SaleCommon Stock | 10,000 | $50.12 | $501,154.00 |
DisclosureSEC source: 0001209191-17-063325 · doc4.xml · nonDerivative · entry 1 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,916 F1 · kind: The sale of 10,000 shares of AMN Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in this row represents a weighted average price of $50.1154 per share. These shares were sold in multiple transactions at prices ranging from $49.90 to $50.325, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 29, 2017 Filed Dec 2, 2017 00:18 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
SaleCommon Stock | 15,272 | $49.00 | $748,328.00 |
DisclosureSEC source: 0001209191-17-063323 · doc4.xml · nonDerivative · entry 1 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 F1 · kind: The sale of 15,272 shares of AMN Common Stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 01:11 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 2,500 | $47.03 | $117,575.00 |
DisclosureSEC source: 0001209191-17-062762 · doc4.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,525 Read SEC document |
| November 09, 2017 Filed Nov 14, 2017 00:21 UTC |
STERN ANDREW MDirector
|
SaleCommon Stock | 10,000 | $42.89 | $428,911.00 |
DisclosureSEC source: 0001209191-17-060464 · doc4.xml · nonDerivative · entry 1 STERN ANDREW M · CIK 0001158585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,668 F1 · price: The price reported on this Form 4 represents a weighted average price of $42.8911 per share. These shares were sold in multiple transactions at prices ranging from $42.8424 to $42.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 09, 2017 Filed Dec 20, 2017 22:01 UTC |
SALKA SUSAN RDirector · President and CEO
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066670 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,850 F2 · kind: The reporting person transferred 10,000 shares of AMN Common Stock as a gift to charity. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 23:21 UTC |
HARRIS R JEFFREYDirector
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-059652 · doc4.xml · nonDerivative · entry 1 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,912 F1 · kind: The reporting person transferred 5,000 shares of AMN Common Stock as a gift to charity. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 01:06 UTC |
SALKA SUSAN RDirector · President and CEO
|
SaleCommon Stock | 74,456 | $41.86 | $3,116,564.36 |
DisclosureSEC source: 0001209191-17-059665 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,561 F1 · kind: The sale of 74,456 shares of Common Stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in this row represents a weighted average price of $41.8578 per share. These shares were sold in multiple transactions at prices ranging from $40.55 to $42.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 22:36 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
SaleCommon Stock | 6,906 | $46.00 | $317,676.00 |
DisclosureSEC source: 0001209191-17-055436 · doc4.xml · nonDerivative · entry 1 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,772 F1 · kind: The sale of 6,906 shares of AMN Common Stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 13, 2017 Filed Jun 14, 2017 21:22 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 1,500 | $36.71 | $55,057.50 |
DisclosureSEC source: 0001209191-17-039872 · doc4.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,025 Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 18:12 UTC |
WHEAT DOUGLAS DDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027651 · doc4.xml · derivative · entry 3 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 20, 2016 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2017 Annual Meeting of Stockholders. The Company's 2017 Annual Meeting of Stockholders was held on April 19, 2017. Accordingly, the number of Restricted Stock Units identified in this row (i.e. 3,793) vested on April 19, 2017. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 18:12 UTC |
WHEAT DOUGLAS DDirector
|
Exercise / conversionCommon Stock | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027651 · doc4.xml · nonDerivative · entry 1 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 18:07 UTC |
Weaver Paul EDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027649 · doc4.xml · derivative · entry 3 Weaver Paul E · CIK 0001363498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 20, 2016 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2017 Annual Meeting of Stockholders. The Company's 2017 Annual Meeting of Stockholders was held on April 19, 2017. Accordingly, the number of Restricted Stock Units identified in this row (i.e. 3,793) vested on April 19, 2017. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 18:07 UTC |
Weaver Paul EDirector
|
Exercise / conversionCommon Stock | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027649 · doc4.xml · nonDerivative · entry 1 Weaver Paul E · CIK 0001363498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 17:59 UTC |
Marsh Martha H.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027643 · doc4.xml · derivative · entry 3 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 20, 2016 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2017 Annual Meeting of Stockholders. The Company's 2017 Annual Meeting of Stockholders was held on April 19, 2017. Accordingly, the number of Restricted Stock Units identified in this row (i.e. 3,793) vested on April 19, 2017. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 17:59 UTC |
Marsh Martha H.Director
|
Exercise / conversionCommon Stock | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027643 · doc4.xml · nonDerivative · entry 1 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 17:47 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027639 · doc4.xml · derivative · entry 3 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 20, 2016 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2017 Annual Meeting of Stockholders. The Company's 2017 Annual Meeting of Stockholders was held on April 19, 2017. Accordingly, the number of Restricted Stock Units identified in this row (i.e. 3,793) vested on April 19, 2017. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 17:47 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027639 · doc4.xml · nonDerivative · entry 1 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 17:37 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027636 · doc4.xml · derivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 20, 2016 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2017 Annual Meeting of Stockholders. The Company's 2017 Annual Meeting of Stockholders was held on April 19, 2017. Accordingly, the number of Restricted Stock Units identified in this row (i.e. 3,793) vested on April 19, 2017. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 17:37 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionCommon Stock | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027636 · doc4.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 18:12 UTC |
WHEAT DOUGLAS DDirector
|
GrantRestricted Stock Units · Derivative | 3,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027651 · doc4.xml · derivative · entry 2 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 Underlying: Common Stock · 3,365 shares Expires not disclosed F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Stockholders. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 18:07 UTC |
Weaver Paul EDirector
|
GrantRestricted Stock Units · Derivative | 3,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027649 · doc4.xml · derivative · entry 2 Weaver Paul E · CIK 0001363498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 Underlying: Common Stock · 3,365 shares Expires not disclosed F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Stockholders. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 18:02 UTC |
STERN ANDREW MDirector
|
GrantRestricted Stock Units · Derivative | 3,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027646 · doc4.xml · derivative · entry 1 STERN ANDREW M · CIK 0001158585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 Underlying: Common Stock · 3,365 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Stockholders. At the reporting person's irrevocable election, the number of Restricted Stock Units identified in this row (i.e. 3,365) settle on the date of the director's termination of service with the Company. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 17:51 UTC |
JOHNS MICHAEL M EDirector
|
GrantRestricted Stock Units · Derivative | 3,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027641 · doc4.xml · derivative · entry 1 JOHNS MICHAEL M E · CIK 0001221096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 Underlying: Common Stock · 3,365 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Stockholders. At the reporting person's irrevocable election, the number of Restricted Stock Units identified in this row (i.e. 3,365) settle on the date of the director's termination of service with the Company. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 17:59 UTC |
Marsh Martha H.Director
|
GrantRestricted Stock Units · Derivative | 3,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027643 · doc4.xml · derivative · entry 2 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 Underlying: Common Stock · 3,365 shares Expires not disclosed F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Stockholders. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 17:47 UTC |
HARRIS R JEFFREYDirector
|
GrantRestricted Stock Units · Derivative | 3,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027639 · doc4.xml · derivative · entry 2 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 Underlying: Common Stock · 3,365 shares Expires not disclosed F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Stockholders. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 17:37 UTC |
FOLETTA MARK GDirector
|
GrantRestricted Stock Units · Derivative | 3,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027636 · doc4.xml · derivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 Underlying: Common Stock · 3,365 shares Expires not disclosed F2 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Stockholders. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 00:10 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
SaleCommon Stock | 6,904 | $43.00 | $296,872.00 |
DisclosureSEC source: 0001209191-17-021867 · doc4.xml · nonDerivative · entry 1 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,678 F1 · kind: The sale of 6,904 shares of AMN Common Stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 19:28 UTC |
STERN ANDREW MDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 5,168 | $0.00 Strike: $16.18 | $0.00 |
DisclosureSEC source: 0001209191-17-018213 · doc4.xml · derivative · entry 7 STERN ANDREW M · CIK 0001158585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,168 shares Expires 2018-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 19:28 UTC |
STERN ANDREW MDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 3,482 | $0.00 Strike: $24.95 | $0.00 |
DisclosureSEC source: 0001209191-17-018213 · doc4.xml · derivative · entry 6 STERN ANDREW M · CIK 0001158585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,482 shares Expires 2017-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 19:28 UTC |
STERN ANDREW MDirector
|
SaleCommon Stock | 4,560 | $41.63 | $189,811.82 |
DisclosureSEC source: 0001209191-17-018213 · doc4.xml · nonDerivative · entry 5 STERN ANDREW M · CIK 0001158585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,668 F1 · price: The price reported in this row represents a weighted average price of $41.6254 per share. These shares were sold in multiple transactions at prices ranging from $41.51 to $41.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.